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The scope of my talk as represented by its title 
encompasses a very large field which time does not 
allow me to cover in its entirety. Therefore, I will 
limit my remarks to one very specific area where 
chemical changes in amniotic fluid could be used to 
predict fetal maturity. 
An ever present dilemma in modern obstetrical 
management is the proper timing of delivery of the 
fetus in situations where complications either threaten 
its own life in utero or significantly affect maternal 
morbidity. In such situations the obstetrician is con-
fronted with the equivocal choice between premature 
delivery and the high risk to the fetus of continued 
intrauterine existence. In addition, he is placed in 
a unique position where any sort of direct communi-
cation with one of his "patients," namely the fetus, 
is nearly impossible. In the past, the delivery of 
obstetrical care to the fetus and the monitoring of 
its well-being were possible only through the agency 
of the maternal organism. To improve upon this 
situation, methods had to be found that would give 
a more direct and accurate reflection of fetal status. 
Hence, as complete a collection as possible of ac-
curate indices relating to fetal maturity is of great 
importance to the obstetrician. Some of the notable 
complications of pregnancy in which these indices 
would be of value are diabetes, toxemia, erythro-
blastosis fetalis, and previous poor obstetrical his-
tory: for example, cases requiring repeat cesarean 
sections or abruptio placentae. 
In the late fifties (Jeffccate and Scott, 1959), it 
was recognized that the fetus contributed metabolic 
products and secretions to the amniotic fluid, and this 
encouraged many researchers to investigate a pos-
sible correlation between the status of the fetus and 
the amniotic fluid constituents. At that time, how-
ever, the technique for amniocentesis had not been 
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generally accepted, although it has been known 
for over two decades, and the progress of research 
was slow. With the acceptance of amniocentesis as 
an aggressive means of diagnosis, the procedure for 
withdrawal of amniotic fluid led to several investi-
gations into fetal maturity indices. Amongst these 
were the measurements of amniotic fluid creatinine 
(Pitkin and Zwirek, 1967; Liley, 1961; Mandel-
baum, et al, 1967), bilirubin (Droegemueller, 
1969), and the examination of the cytology of cells 
stained with Nile Blue Sulfate (Brosens and Gor-
don, 1966; Anderson and Griffiths, 1968). These 
indices are now used in a fairly routine manner in 
the management of obstetrical patients, and I shall 
not go into any detail about them. A further and 
more specialized offshoot of this research has been 
the measurement of certain other specific amniotic 
fluid constituents that might lead, in the near future, 
to a more reliable picture of fetal well-being or 
distress in addition to fetal maturity. 
In spite of all the advances that have been made, 
there still exists an appreciable degree of perinatal 
mortality today, the major contributor being res-
piratory distress due to premature delivery. An es-
timated 25,000 newborn deaths annually in the United 
States are attributed to this cause (Gluck, 1971). 
The stage of fetal lung maturity at the time of de-
livery is of prime importance as it most often 
entirely determines the survival or death of the neo-
nate. For the neonate to survive, its lung has to 
assume immediate function with the change from 
an intra to an extrauterine environment. Thus, in 
the case of a pregnancy complicated, for example, 
by the presence of maternal diabetes or toxemia, the 
obstetrician has to walk a tightrope where he must 
maintain, to the best of his ability, a critical balance 
between neonatal death due to respiratory distress 
(hyaline membrane disease) and the threat of intra-
uterine demise caused by maternal disease. The 
frustrating decision that has to be made is, "When 
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is the earliest the obstetrician can deliver a healthy 
baby that will survive?" 
At the moment, what seems to be a ray of hope 
on the horizon for the obstetrician has resulted from 
research that was started in the early fifties on the 
phospholipid content and its patterns in the fetal 
lung. As early as 1929, von Neergaard (von Neer-
gaard, 1929), demonstrated that surface forces con-
tribute significantly to the retractive pressure of the. 
lung. At that time he postulated a lung coating to 
explain these observations. In 1955, Pattie (Pattie, 
1955), showed that pulmonary edema foam con-
tained some substance, or substances, that stabilized 
the tiny bubbles seen characteristically in such foam, 
and in 1957, Clements (Clements, 1957) and Avery 
and Mead (Avery and Mead, 1959) identified a sur-
face tension lowering substance in lung tissue. These 
observations, subsequently confirmed by several 
workers, led to the conclusive identification of this 
surface tension lowering compound, called a sur-
factant, as being a,,B-dipalmitoyl lecithin. 
l am now going to highlight some of the sig-
nificant laboratory findings that have led us to 
the point at which we are today. In 1961, Klaus 
and his co-workers (Klaus, et al, 1961) showed 
that bovine lung foam contained a mixture of sev-
eral surface active compounds, the major constitu-
ent being dipalmitoyl lecithin. The other surface 
active compounds he found were sphingomyelin, 
phosphatidyl inositol, phosphatidyl dimethylethano-
lamine, and lysolecithin. The chemical structures 
of some of these compounds are depicted in 
Fig. 1. During the sixties, significant details of 
the surfactant system were gleaned through the work 
of Morgan (Morgan, et al, 1965), Fujiwara (Fu-
jiwara, et al, 1968), and Gluck (Gluck, Kulovich, 
et al, 1967, 1970) all working independently. 
Morgan and his group worked on the identification 
of the various components of the surface active 
system in alveolar and whole lung homogenates in 
the dog. They found that of the total lipids found 
in dog lung, phospholipids constituted the major 
group at 7 4.1 % . Of this group, phosphatidyl choline 
was the major component. Phosphatidyl ethanola-
mine, lysophosphatidyl choline, which is lysoleci-
thin, and sphingomyelin were also found, but in 
much smaller quantities. These are all surface active 
along with dipalmitoyl lecithin or phosphatidyl 
choline, but phosphatidyl choline seems to be 
by far the major component. As seen in Fig. 
1, the lecithins are characterized by fatty acid groups 
Ri and R 2 on the a and ,B positions of the tri-
glyceride backbone. Fujiwara and his associates 
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Fig. I-Chemical structures of some phospholipids. 
(Fujiwara, et al, 1968) reported on the significance 
of these fatty acids, which are normally C14 to C1s 
fatty acids, and the total concentration of individual 
phospholipids in the developing fetal lamb lung. 
He took fetuses at three different ages of gesta-
tion; immature (99-119 days) , transitional (120-
134 days) and term (135-145 days) . Gestational 
age in sheep is about 140 days. He found that 
as gestation proceeded toward term, the amount 
of phospholipids, both on a weight basis and 
on a total phospholipid basis, increased. He also 
found that phosphatidyl choline increased while 
phosphatidyl ethanolamine decreased, and this will 
be an important factor when we talk about the bio-
synthetic pathways. The significance of the fatty 
acids was demonstrated by the observation that the 
percentage of saturated fatty acids in the whole 
molecule increased towards term, whereas the per-
centage of saturated fatty acids at the f3 position 
stayed fairly constant. This means that now we have 
two parameters by which the state of development 
of the fetal lung can be assessed; in general, the 
total amount of lecithin present and specifically, the 
BHATNAGAR: CHEMICAL CHANGES IN AMNIOTIC FLUID 39 
amount of lecithin esterified with saturated fatty 
acids. To test the hypothesis that lung maturity is 
reflected by an increase in saturated lecithins, and 
vice versa, Brumley and his colleagues measured 
the surface tension and phospholipid content of 
normal lungs and lungs from infants with respira-
tory distress syndrome (Brumley, et al, 1967). 
Brumiey's data is shown in Table 1. As I men-
they parallel one another and coritiriue to do so 
until about the 25th week of gestation where lec-
ithin starts rising slightly more rapidly than. sphin-
gomyelin. At about the 30th to 34th week there is 
a sharp increase in lecithin concentration till term, 
whereas sphingomyelin plateaus and starts going 
dowrt again. The reason for this dramatic rise in 
lecithin biosynthesis at about the 32nd to 34th week 
TABLE 1 
Phospholipid Analysis of Lung Tissue* 
Phosphatidyl choline Saturated fatty acids 
Phospholipid (as % of total (as % in phdsphatidyl Surface Tension 
Condition (mg/ g wet weight) phospholipid) choline) (dynes / cm) 
Infants with respiratory 
distress 10.4 46.4 64.7 23 
Infants recovered from 
respiratory distress 17 .4 56.9 70.4 3.0 
Infants without respiratory 
distress 22.3 58.8 84.2 6.0 
Normal adults 16.8 45 .8 80.8 6.0 
~ata adapted from Brumley, Hodson, and Avery, 1967. 
tioned earlier, what the surfactant does is lower 
surface tension and thus produce more elasticity 
in the lung. in adults the surface tension of trachial 
aspirates is somewhere of the order of 6 dynes/ cm., 
and the total phospholipid content is 16.8 mg/gm 
wet weight. The content of phosphatidyl choline, as 
a percentage of total phospholipids, is about 45.8%. 
In the infant with no respiratory distress syndrome 
these values are very close to those in the normal 
adult. With respiratory distress syndrome the sur-
face tension of trachial aspirates becomes much 
higher. The amount of phospholipid is considerably 
lower compared to that of adults and infants with 
no respiratory distress syndrome, as are the amounts 
of phosphatidyl choline and saturated fatty acid. As 
the neonate recovers from the respiratory distress 
situation, these values slowly start returning to 
normal. This means that there is a valid justification 
for implicating the amount of phospholipid, speci-
fically phosphatidyl cholille, in the development of 
fetal lung. Gluck and his group (Gluck, 1971; 
Gluck, Kulovich, et al, 1967, 1970) reported 
extensively in the middle and late sixties on the 
biochemistry of surfactant production in the lung. 
They measured the amount of dipalmatoyl lecithin 
and sphingomyelin in amniotic fluid in humans 
(Gluck, 1971), with the results shown in Fig. 2. Gluck 
found that early in gestation, the amount of lecithin 
is slightly lower than that of sphingomyelin but that 
can be partially explained by the.picture of the bio-
synthetic pathways of these phosph9lipids (Fig. 3). 
The lecithins are synthesized niainly by two .routes. 
In pathway 1 (the ch9line incorporation pathway) 
an a,,B-di-substituted d~glyceride reacts with cytidine-
diphospho choline (CDP-choline) thereby incorpo-
rating choline into the molecule which results in 
phosphatidyl choline, or lecithin: In pathway 2 (the 
methylatidn pathway) the a,,B-diglyceride incorporates 
ethanolamine through the agency of cytidine-diph-
osphoethanolainine ( CDP-ethanolarriine) resulting in 
phosphatidyl ethanolamine (PE) which by subsequent 
methylations by S-adenosyltnethionine gives phos7 
phatidyl methyl ethanolamine (PME) , phosphatidyl 
dimethyl <;:thanolamine (PDME), and finally lecithin. 
These two pathways need to be studied in greater 
detail than they have been, but certain facets about 
them are known. It has been shown that the dramatic 
surge in lecithin at the 33rd to 34th week appears 
because of the activation of pathway 1, that is, the 
choline incorporation pathway. Gluck has evidence, 
primarily clinical in nature, that the methylation 
pathway is the primary mode of lecithin biosynthesis 
in early gestation, but that on .or after about the 34th 
week, the choline incorporation pathway becomes 
the more important (Gluck, 1971). He found that 
when he analyzed respiratory distress syndrome 
cases in prematures, most of them were acidotic 
and/or hypothermic. He also found that neither 
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acidosis nor hypothermia were associated with 
clinical respiratory distress syndrome in the full-term 
infant. When trachial aspirates were obtained from 
prenatal, or frbm premature infants while they were 
still hypothermic, he found little or no phosphatidyl 
dimethyl ethancilamine which meant that the ineth-
ylation pathway was not functioning. As the infants 
were put into an incubator and temperature brought 
up, increasing amounts of PDME were found in 
trachial aspirates which indicated that the heat sup-
plied to them was activating this pathway. These 
findings suggested that the methylation pathway is 
vulnerable to external insult. Yet if this were the case, 
then some full-term infants should also show re-
spiratory distress, which they do not. Gluck's ex-
planation for this is based on his evidence that 
early in gestation the methylation pathway is the 
more important btit at about the 35th week the 
choline incorporation pathway takes over causing the 
surge of lecithin. As the choiine incorporation path-
way is not vulnerable to external insult, it is pro-
ducing sufficient quantities of surfactant for the 
full-term infant not to have respiratory distress; Thus 
the premature infant is at a disadvantage because 
at around 30-34 weeks gestation when the methy-
lation pathway is dominant and vulnerable to external 
insult, the choline incorporation pathway has not 
yet assumed maximal function, and hence, sufficient 
surfactant is not being produced. The only lab find-
ing that Gluck reports in support of his hypothesis 
is that in vitro, the methylation pathway is markedly 
inhibited below a pH of 7.2; in vivo, exposure to 
cold or hypothermia or hypoxia causes acidosis in 
the neonate, which could then inhibit the methyl-
ation pathway. 
With all this data, we now have the basis for 
developing a method for the prediction of re~ 
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Fig. 2-ConcentratiOns of sphingomyelin and lecithin in 
amniotic fluid during gestation. (Reprinted with permission 
from Gluck, Hosp. Pract. 6:45, 1971.) 
spiratory distress in the neonate by measuring lec-
ithin and sphingomyelin in amniotic fluid. Although 
lecithin and sphingomyelin are measured individu-
ally, the results are reported in terms of the- ratio 
of lecithin to sphirigomyelin. Once the ratio starts 
getting higher than 1 or 2, one might be able to 
give some indicatiori about whether respiratory 
distress could be predicted in that fetus were it de-
livered at that time. The method we have developed 
and are using at present is a modification of G!uck's 
original method (Gluck, Kulovich, et al, 1971) and 
is - outlined in Fig. 4. Three inililiters of amniotic 
fluid are taken to which are added 3 ml of methanol 
and 6 ml of chloroform in a centrifuge tube. The 
whole is extracted once, centrifuged, and the lower 
Phosphatidyl choline 
(Lecithin) 
Phosphatidyl-
ethanolamine 
_(PE) 
Phosphatidyl -
methylethanolamine 
(PME) 
Phosphatidyl-
diinethylethanolamine 
(PDME) 
Fig. 3- Two postulated pathways for lecithin biosynthesis. 
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3 ml Amniotic Fluid 
l 3 ml Methanol 6 ml Chloroform 
Extract once and centrifuge 
i 
Separate lower Chloroform: Methanol layer 
i 
Evaporate and reconstitute in 100 µl Chloroform 
i 
Transfer to Silica Gel H TLC Plate 
i 
Chromatograph in Chloroform-Methanol-Acetic Acid-0.93 aq. NaCl 
70 : i 25 : 4.8 3.2 
a) Place chromatoplate in chamber saturated with iodine vapor 
b) Remove chromatoplate from chamber, mark spots, wait for iodine to vaporize 
c) Carefully scrape off the silica gel from marked areas 
i 
Measure phosphorous content by the method of Fiske & Subbarow (Fiske and Subbarow, 1925; King, 1938) 
Fig. 4- Methodologic flow sheet. 
chloroform methanol layer is removed, evaporated, 
and reconstituted in 100 µ,l of chloroform. This is 
then transferred to a thin-layer plate which is run in 
the system, chloroform-methanol-acetic acid-0.9% 
aq. NaO (70:25:4.8:3.2). We found this system to 
be better than the old chloroform-methanoi-water 
ones which are normally used for phospholipids: 
Lecithin and sphingomyelin are visualized by placing 
the thin-layer · plate in a chamber saturated with 
iodine vapor. The iodine is deposited reversibly on 
the areas where the lecithin and sphingomyelin are 
located. The spots are then marked, scraped off, and 
after the iodine has vaporized, the phosphorus 
content of the spots is measured by a modification 
of the Fiske and Subbarow method (Fiske and Sub-
barow, 1925; King, 1938). As one mole of phos-
phorus corresponds to one mole of lecithin and 
sphingomyelin, by measuring the amount of phos-
phorus, we can calculate the absolute amounts of 
lecithin and sphingomyelin and hence get the ratio 
of one to the other. The test we have developed 
takes an average technician approximately 3 hours 
for 6 quantitative determinations. For a quick but 
qualitative result, the test can be shortened by 
eliminating the quantitative step, spraying the thin-
layer plate with a phosphorus specific spray (Ditt-
mer and Lester, 1964) once it comes out of its 
developing solvent system, and then estimating in 
gross terms the amounts of lecithin and sphingo-
myelin by the visual intensities of their spots. 
In our laboratory, we take a ratio of 2 or 
greater tO predict fetal lung maturity. Gluck and his 
group reported a few months ago that based on the 
results of 302 amniocenteses from 272 pregnancies 
using their method of monitoring ·the phospholipids, 
not one single case of respiratory distress occurred 
(Gluck, Kulovich, et al, 1971). Our experience 
here at the Medical College of Virginia is of shorter 
duration. After 49 complicated pregnancies which 
we have monitored through 63 amniocenteses, we 
have noi encountered any instance of respiratory 
distress, and among these we have had four notable 
cases : three of diabetes and one of Rh disease. The 
Rh disease patient was delivered at 331/i weeks after 
continuous monitoring of her lecithin-sphingomyelin 
ratios, and she delivered a healthy viable infant whose 
weight was compatible with dates. The three dia-
betics were delivered at 34, 35, and 36 weeks, and 
all delivered healthy viable infants showing no signs 
of respiratory distress. 
Although the lecithin-sphingomyelin ratio seems 
to be going a long way in alleviating the frustration 
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of obstetricians, it should still be used with caution 
because the volume of data is not sufficient to show 
what would happen if one were to get a false posi-
tive, if one indeed ever gets false positives. The next 
big step that needs to be taken is a detailed study 
of the two major biosynthetic pathways for ledthin 
and a study of the characteristics and properties of 
the enzymes involved. If a compound could be 
found to induce one or both of these enzymes, this 
information would provide a much wanted tool in 
the hands of an obstetrician or pediatrician for deal-
ing with the fetus or neonate. Such information 
would also be of great significance in cases of res-
piratory distress syndrome which are independent 
of obstetrical management, such as premature labor. 
In this instance, the physician is confronted with a 
situation not of his own making and has to deal with 
it as quickly and as best he can. At present, we are 
able, with the use of the described test, to predict 
the possibility of respiratory distress and thus have 
the necessary facilities such as an incubator or a 
respirator ready for the neonate immediately after 
delivery. But of even greater benefit would be the 
discovery of a compound drug which would induce 
the choline incorporation pathway. This, as i 
mentioned earlier, is insensitive to external insult, 
and once biosynthesis of lecithin has been induced 
by means of the pathway, the neonate itself can take 
over the job it is supposed to do. A further goal 
is the compiling of sufficient data such that a sig-
nificant statistical analysis can be made concerning 
the accuracy of predicting the severity of respiratory 
distress associated with specific ranges of the 
lecithin/ sphingomyelin ratio. 
Finally, I would like to express my apprecia-
tion to our excellent housestaff who have been very 
patient in supplying me with samples of amniotic 
fluid as uncontaminated with blood as possible and 
also my very deep gratitude to Dr. Dunn for his 
constant and very enthusiastic encouragement of this 
work. 
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